Bottom line
Is SMOT a good fund? The bottom line
SMOT is a managed small-cap ETF from VanEck.
Its expense ratio is 0.49% — about $49 a year on every $10,000 invested, cheaper than 89% of small-cap funds we track.
It returned +6.5% over one year (as of Dec 31, 2025, per its prospectus).
With $334 million in net assets and 110 holdings, its largest position is Acuity Inc (1.7%) and the top 10 make up 14.8% of the portfolio.
What stands out
- Low cost: cheaper than 89% of small-cap peers
Updated Nov 19, 2026
What SMOT invests in
VanEck Morningstar SMID Moat ETF (the Fund) seeks to track as closely as possible, before fees and expenses, the price and yield performance of the Morningstar US Small-Mid Cap Moat Focus Index SM (the Morningstar US Small-Mid Cap Moat Focus Index or the Index).
The Fund normally invests at least 80% of its total assets in securities that comprise the Funds benchmark index. For purposes of this policy, the term assets means net assets plus the amount of any borrowings for investment purposes. The Morningstar US Small-Mid Cap Moat Focus Index is comprised of small- and medium-capitalization companies as defined by Morningstar, Inc. (Morningstar or the Index provider), that Morningstar determines have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors (wide and narrow moat companies). The quantitative factors used by Morningstar to identify competitive advantages currently include historical and projected returns on invested capital relative to cost of capital. The qualitative factors used by Morningstar to identify competitive advantages currently include customer switching…
From the fund's prospectus (filed Jan 27, 2026).
SMOT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SMOT | +6.5% | — | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What SMOT costs
On a $10,000 investment, SMOT's 0.49% expense ratio costs about $49 a year. The prospectus estimates $616 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
SMOT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Acuity Inc | 1.70% |
| 2 | Bio-Techne Corp | 1.66% |
| 3 | Masco Corp | 1.56% |
| 4 | Biogen Inc | 1.45% |
| 5 | Royalty Pharma PLC | 1.45% |
| 6 | Block Inc | 1.42% |
| 7 | Corteva Inc | 1.42% |
| 8 | Amcor PLC | 1.39% |
| 9 | Gentex Corp | 1.39% |
| 10 | Norwegian Cruise Line Holdings Ltd | 1.38% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 14.8% of the fund. See all top 25 holdings and asset mix →